HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-JUN-21 7N5Y TITLE FRAGMENT-BASED DRUG DESIGN OF A NOVEL, COVALENT BRUTON'S TYROSINE TITLE 2 KINASE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 416-693; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS CYTOPLASMIC TYROSINE KINASE, TRANSCRIPTIONAL REGULATION, NUCLEAR KEYWDS 2 FACTOR-KAPPAB, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.R.DOUGAN,J.D.LAWSON REVDAT 4 06-NOV-24 7N5Y 1 REMARK REVDAT 3 18-OCT-23 7N5Y 1 REMARK REVDAT 2 22-SEP-21 7N5Y 1 JRNL REVDAT 1 08-SEP-21 7N5Y 0 JRNL AUTH M.SABAT,D.R.DOUGAN,B.KNIGHT,J.D.LAWSON,N.SCORAH,C.R.SMITH, JRNL AUTH 2 E.R.TAYLOR,P.VU,C.WYRICK,H.WANG,D.BALAKRISHNA,M.HIXON, JRNL AUTH 3 L.MADAKAMUTIL,D.MCCONN JRNL TITL DISCOVERY OF THE BRUTON'S TYROSINE KINASE INHIBITOR CLINICAL JRNL TITL 2 CANDIDATE TAK-020 ( S JRNL TITL 3 )-5-(1-((1-ACRYLOYLPYRROLIDIN-3-YL)OXY)ISOQUINOLIN-3-YL)-2, JRNL TITL 4 4-DIHYDRO-3 H -1,2,4-TRIAZOL-3-ONE, BY FRAGMENT-BASED DRUG JRNL TITL 5 DESIGN. JRNL REF J.MED.CHEM. V. 64 12893 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34448571 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01026 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1759 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2208 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.80000 REMARK 3 B22 (A**2) : -0.25000 REMARK 3 B33 (A**2) : -0.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.127 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.121 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.076 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.009 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2313 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2152 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3114 ; 1.426 ; 1.656 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4972 ; 1.329 ; 1.580 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 269 ; 7.429 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;30.244 ;22.541 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 427 ;12.727 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;13.637 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 280 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2574 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 537 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 5 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 389 A 492 REMARK 3 RESIDUE RANGE : A 493 A 552 REMARK 3 RESIDUE RANGE : A 556 A 658 REMARK 3 RESIDUE RANGE : A 701 A 701 REMARK 3 RESIDUE RANGE : A 702 A 702 REMARK 3 ORIGIN FOR THE GROUP (A): -16.435 -15.875 5.853 REMARK 3 T TENSOR REMARK 3 T11: 0.0120 T22: 0.0113 REMARK 3 T33: 0.0008 T12: 0.0051 REMARK 3 T13: 0.0013 T23: 0.0015 REMARK 3 L TENSOR REMARK 3 L11: 0.0612 L22: 0.3287 REMARK 3 L33: 0.1515 L12: 0.0439 REMARK 3 L13: 0.0688 L23: 0.0073 REMARK 3 S TENSOR REMARK 3 S11: -0.0084 S12: -0.0193 S13: -0.0045 REMARK 3 S21: 0.0003 S22: 0.0170 S23: -0.0042 REMARK 3 S31: -0.0221 S32: -0.0210 S33: -0.0086 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 7N5Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1000257383. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26776 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.65000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4Z3V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% POLYETHYLENE GLYCOL 4000, 20% REMARK 280 GLYCEROL, 0.1M IMIDAZOLE/MES, PH 6.5 AND 0.12M ALCOHOL MIXTURE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.35850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.36450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.35850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.36450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 377 REMARK 465 PRO A 378 REMARK 465 LEU A 379 REMARK 465 PRO A 380 REMARK 465 GLY A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 SER A 659 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -6.42 78.09 REMARK 500 ASP A 521 48.22 -154.25 REMARK 500 TYR A 571 26.82 -152.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1018 DISTANCE = 6.94 ANGSTROMS DBREF 7N5Y A 382 659 UNP Q06187 BTK_HUMAN 416 693 SEQADV 7N5Y GLY A 377 UNP Q06187 EXPRESSION TAG SEQADV 7N5Y PRO A 378 UNP Q06187 EXPRESSION TAG SEQADV 7N5Y LEU A 379 UNP Q06187 EXPRESSION TAG SEQADV 7N5Y PRO A 380 UNP Q06187 EXPRESSION TAG SEQADV 7N5Y GLY A 381 UNP Q06187 EXPRESSION TAG SEQRES 1 A 283 GLY PRO LEU PRO GLY LYS ASN ALA PRO SER THR ALA GLY SEQRES 2 A 283 LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU SEQRES 3 A 283 THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL SEQRES 4 A 283 VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA SEQRES 5 A 283 ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP GLU SEQRES 6 A 283 PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS SEQRES 7 A 283 GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN SEQRES 8 A 283 ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY SEQRES 9 A 283 CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE SEQRES 10 A 283 GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS SEQRES 11 A 283 GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS SEQRES 12 A 283 ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN SEQRES 13 A 283 GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR SEQRES 14 A 283 VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER LYS SEQRES 15 A 283 PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SEQRES 16 A 283 SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY SEQRES 17 A 283 VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO SEQRES 18 A 283 TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE SEQRES 19 A 283 ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER SEQRES 20 A 283 GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU SEQRES 21 A 283 LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER SEQRES 22 A 283 ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET IMD A 701 5 HET 0CI A 702 26 HET DMS A 703 4 HETNAM IMD IMIDAZOLE HETNAM 0CI 5-(1-{[(3S)-1-PROPANOYLPYRROLIDIN-3-YL]OXY}ISOQUINOLIN- HETNAM 2 0CI 3-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 IMD C3 H5 N2 1+ FORMUL 3 0CI C18 H19 N5 O3 FORMUL 4 DMS C2 H6 O S FORMUL 5 HOH *218(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 LEU A 482 GLU A 488 1 7 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O VAL A 416 N GLY A 409 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 3 GLY A 480 CYS A 481 0 SHEET 2 AA2 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 AA2 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 LINK SG CYS A 481 C1 0CI A 702 1555 1555 1.64 CISPEP 1 ARG A 468 PRO A 469 0 -0.30 CRYST1 72.717 104.729 38.050 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013752 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009548 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026281 0.00000